The Norwegian Radium Hospital, The Research Building
Marina Vietri from Institute for Cancer Research and Centre for Cancer Biomedicine is awarded H.M. the King's Gold Medal for best thesis of the Faculty of Medicine. She will receive the medal at the annual celebration of the University of Oslo in the University Aula on 2nd September.
On the 17th of June six research prizes were awarded to scientists from Oslo University Hospital. CCBs Jarle Bruun was among the prize winners. Jarle Bruun is a member of Ragnhild A. Lothe's group at the Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital.
Scientist Lene Malerød and senior scientist Kaisa Haglund in Harald Stenmark’s group at Institute for Cancer Research and Centre for Cancer Biomedicine published a cover story in the March-issue 2016 of Cell Cycle. The work has been performed in collaboration with scientists at the Department of Medical Genetics (Oslo University Hospital), Department of Anatomy (University of Oslo) and Department of Chemistry (University of Oslo). A News and Views of the paper was written by Associate Professor Kouichi Funato and coworkers (Department of Biofunctional Science and Technology, Graduate School of Biosphere Science, Hiroshima University, Hiroshima, Japan) and published the 22nd April 2016 at Cell Cycle online.
We congratulate CCB's PI Håvard Danielsen, director of The Institute for Cancer Genetics and Informatics, Oslo University Hospital, with the prestigious Lighthouse Project grant for the DoMore! project.
The DoMore! project focuses on heterogeneity in cancer. The funding is 60 million NOK over a five-year period.
In a recent issue of Journal of Cell Biology, PhD student Liliane Christ at Institute for Cancer Research and Centre for Cancer Biomedicine provides new insight into how daughter cells are separated during the end of cell division. In the same issue, a “Biobytes” podcast with group leader Harald Stenmark and co-corresponding author Coen Campsteijn explains the importance of this work, as does a commentary article by two external experts in the field.
We congratulate CCB co-director Ragnhild A. Lothe from the Department of Molecular Oncology at the Institute for Cancer Research with achieving the substantial NFR TOPPFORSK funding grant for the project “Modeling tumor heterogeneity in colorectal cancer management”.
The ongoing work of CCB's Camilla Raiborg has recently been presented on the Norwegian popular science website forskning.no as well as on the Norwegian Cancer Society web page. Raiborg is heading the project group "Protein dynamics in tumor suppressor pathways" in Harald Stenmark's group at the Department of Molecular Cell Biology, Institute for Cancer Research, OUH.
Before Christmas The Norwegian Cancer Society and the Research Council of Norway distributed 56 million NOK to various innovation projects. Products that cancer patients are in need of will be developed by these projects. TTOs (Technology Transfer Offices) and Inven2 are project leaders for the majority of these projects.
CCB's principal investigator Prof. Kirsten Sandvig recently received a new grant for work with biodegradable nanoparticles through INNO INDIGO which is an innovation-driven initiative for the development and integration of Indian and European research.
CCB congratulates Guro Elisabeth Lind with a two-year Principal Investigator position for the period 2016-2017.